Parlati Francesco 4
4 · Calithera Biosciences, Inc. · Filed Feb 22, 2018
Insider Transaction Report
Form 4
Parlati Francesco
VP, RESEARCH
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-02-20−3,116→ 0 totalExercise: $0.96Exp: 2023-05-22→ Common Stock (3,116 underlying) - Exercise/Conversion
Common Stock
2018-02-20$0.96/sh+3,116$2,991→ 20,488 total - Exercise/Conversion
Common Stock
2018-02-20$0.96/sh+1,979$1,900→ 17,372 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-02-20−1,979→ 0 totalExercise: $0.96Exp: 2023-05-22→ Common Stock (1,979 underlying)
Footnotes (3)
- [F1]Includes 973 and 2,038 shares acquired under the Company's 2014 Employee Stock Purchase Plan on June 9, 2017 and December 8, 2017, respectively.
- [F2]1/48th of the Option vests in equal monthly installments beginning November 15, 2012. The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.
- [F3]1/48th of the Option vests in equal monthly installments one month after May 23, 2013. The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.